Moderna Historical Income Statement

MRNA Stock  USD 43.06  0.33  0.76%   
Historical analysis of Moderna income statement accounts such as Gross Profit of 3.5 B can show how well Moderna performed in making a profits. Evaluating Moderna income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Moderna's future profits or losses.
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Moderna latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Moderna is a good buy for the upcoming year.
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Moderna. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For information on how to trade Moderna Stock refer to our How to Trade Moderna Stock guide.

About Moderna Income Statement Analysis

Moderna Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Moderna shareholders. The income statement also shows Moderna investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Moderna Income Statement Chart

At present, Moderna's Interest Expense is projected to increase significantly based on the last few years of reporting. The current year's Selling General Administrative is expected to grow to about 1.4 B, whereas Total Revenue is forecasted to decline to about 4.9 B.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Moderna. It is also known as Moderna overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.
Most accounts from Moderna's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Moderna current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Moderna. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For information on how to trade Moderna Stock refer to our How to Trade Moderna Stock guide.At present, Moderna's Interest Expense is projected to increase significantly based on the last few years of reporting. The current year's Selling General Administrative is expected to grow to about 1.4 B, whereas Total Revenue is forecasted to decline to about 4.9 B.
 2021 2022 2023 2024 (projected)
Interest Income18M200M405M425.3M
Net Interest Income18M200M363M381.2M

Moderna income statement Correlations

0.640.531.00.040.070.070.990.990.070.94-0.020.850.940.960.950.990.131.00.90.82
0.640.980.670.790.80.80.60.560.80.370.750.940.850.410.380.560.840.640.390.17
0.530.980.560.870.880.880.490.450.880.240.840.890.780.270.250.450.910.530.250.03
1.00.670.560.080.110.110.980.990.110.940.020.870.940.950.940.980.160.990.910.78
0.040.790.870.081.01.00.0-0.051.0-0.271.00.560.38-0.23-0.26-0.041.00.05-0.23-0.43
0.070.80.880.111.01.00.02-0.031.0-0.241.00.580.41-0.21-0.23-0.021.00.07-0.21-0.41
0.070.80.880.111.01.00.02-0.031.0-0.251.00.570.4-0.21-0.24-0.021.00.07-0.21-0.41
0.990.60.490.980.00.020.020.990.020.94-0.060.820.910.950.950.980.080.980.880.83
0.990.560.450.99-0.05-0.03-0.030.99-0.030.97-0.110.80.90.980.970.990.030.990.930.85
0.070.80.880.111.01.01.00.02-0.03-0.251.00.570.4-0.21-0.24-0.021.00.07-0.21-0.42
0.940.370.240.94-0.27-0.24-0.250.940.97-0.25-0.330.650.781.01.00.96-0.190.940.970.91
-0.020.750.840.021.01.01.0-0.06-0.111.0-0.330.50.32-0.29-0.32-0.110.99-0.01-0.29-0.49
0.850.940.890.870.560.580.570.820.80.570.650.50.980.680.660.80.620.860.640.46
0.940.850.780.940.380.410.40.910.90.40.780.320.980.80.790.910.450.940.740.63
0.960.410.270.95-0.23-0.21-0.210.950.98-0.211.0-0.290.680.81.00.97-0.150.950.970.91
0.950.380.250.94-0.26-0.23-0.240.950.97-0.241.0-0.320.660.791.00.97-0.180.950.960.92
0.990.560.450.98-0.04-0.02-0.020.980.99-0.020.96-0.110.80.910.970.970.041.00.90.88
0.130.840.910.161.01.01.00.080.031.0-0.190.990.620.45-0.15-0.180.040.13-0.16-0.36
1.00.640.530.990.050.070.070.980.990.070.94-0.010.860.940.950.951.00.130.890.83
0.90.390.250.91-0.23-0.21-0.210.880.93-0.210.97-0.290.640.740.970.960.9-0.160.890.81
0.820.170.030.78-0.43-0.41-0.410.830.85-0.420.91-0.490.460.630.910.920.88-0.360.830.81
Click cells to compare fundamentals

Moderna Account Relationship Matchups

Moderna income statement Accounts

201920202021202220232024 (projected)
Interest Expense6.6M9.9M18M29M38M39.9M
Selling General Administrative109.6M188.3M567M1.0B1.3B1.4B
Total Revenue48.0M274.5M17.7B19.3B6.8B4.9B
Gross Profit48.0M266.6M15.1B13.8B2.2B3.5B
Other Operating Expenses593.8M1.0B4.4B9.8B11.1B11.6B
Operating Income(545.7M)(763.1M)13.3B9.4B(4.2B)(4.0B)
Net Income From Continuing Ops(514.0M)(747.1M)12.2B8.4B(3.5B)(3.3B)
Ebit(545.7M)(763.1M)13.3B9.4B(3.9B)(3.7B)
Research Development496.3M1.4B2.0B3.3B4.8B5.1B
Cost Of Revenue496.3M7.9M2.6B5.4B4.7B4.9B
Total Operating Expenses593.8M1.0B1.8B4.4B6.4B6.7B
Income Before Tax(514.7M)(744.5M)13.3B9.6B(3.9B)(3.7B)
Total Other Income Expense Net31.0M18.6M(11M)155M297M311.9M
Net Income Applicable To Common Shares(514.0M)(747.1M)12.2B8.4B9.6B10.1B
Net Income(514.0M)(747.1M)12.2B8.4B(4.7B)(4.5B)
Income Tax Expense(695K)2.6M1.1B1.2B772M810.6M
Tax Provision(695K)2.6M1.1B1.2B1.1B1.2B
Net Interest Income31.9M14.8M18M200M363M381.2M
Interest Income38.5M24.7M18M200M405M425.3M
Depreciation And Amortization31.0M31.3M232M348M621M652.1M
Ebitda(514.7M)(731.9M)13.5B9.8B(3.3B)(3.1B)
Reconciled Depreciation31.0M31.3M232M348M499M524.0M
Non Operating Income Net Other31.0M18.6M(11M)155M178.3M187.2M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Moderna offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Moderna's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Moderna Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Moderna Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Moderna. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For information on how to trade Moderna Stock refer to our How to Trade Moderna Stock guide.
You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Moderna. If investors know Moderna will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Moderna listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.85)
Earnings Share
(5.81)
Revenue Per Share
13.275
Quarterly Revenue Growth
0.017
Return On Assets
(0.1)
The market value of Moderna is measured differently than its book value, which is the value of Moderna that is recorded on the company's balance sheet. Investors also form their own opinion of Moderna's value that differs from its market value or its book value, called intrinsic value, which is Moderna's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Moderna's market value can be influenced by many factors that don't directly affect Moderna's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Moderna's value and its price as these two are different measures arrived at by different means. Investors typically determine if Moderna is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Moderna's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.